EMCDDA Home
  • EN
Search

Table TDI-111. Frequency of use of primary drug of clients entering outpatient treatment, 2011 or most recent year available

Part (viii) All cannabis outpatient clients by country and frequency of use (%)

CountryNot used in the past month/ OccasionalOnce a week or less2 - 6 times per weekDailyFrequency known (n) Frequency unknown
Belgium31.68.320.439.7130788
Bulgaria13.034.852.2230
Czech Republic20.528.629.921.040534
Denmark8.022.469.72061265
Germany5.418.232.344.119959
Estonia40.012.032.016.0253
Ireland117.37.421.853.4114222
Greece21.120.624.433.962018
Spain112.77.116.863.490452165
France14.710.717.357.4143732401
Italy225.127.321.626.061721785
Cyprus27.015.415.442.24342
Latvia37.049.729.314.015775
Lithuania
Luxembourg1
Hungary59.120.110.710.0270054
Malta15.613.915.654.9122
Netherlands10.82.410.776.235292104
Austria32.114.828.924.371760
Poland416.224.832.526.51179
Portugal532.211.413.343.15187
Romania8.343.820.827.14818
Slovenia21.426.228.623.8422
Slovakia5.923.045.425.71525
Finland35.323.530.310.911923
Sweden135.414.228.621.896576
United Kingdom6
Croatia57.723.113.65.786730
Turkey
Norway16.213.518.951.4373
Total15.514.522.447.6656569250
 

Notes:

: Indicates no data are available.

Percentages are of clients whose frequency of use is known (n)

(1) Data are from 2010

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

See also Table TDI-18 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013